Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Dual-action GLP-1/GIP receptor agonists like Zepbound can also mimic the action of GIP, a hormone that helps regulate blood sugar levels and metabolism
Most of the research on this drug class was conducted in people with Type 2 diabetes, but it has also been shown to contribute to weight loss and can be prescribed for weight management in people without diabetes
Other side effects of AOM include stomach pains, nausea, constipation and diarrhoea 7
If the vial may have frozen: discard it
Reduce insulin doses by 20 to 30 percent when initiating GLP-1 treatment
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Papatriantafyllou, E., Efthymiou, D., Zoumbaneas, E., et al
